Monoclonal antibodies directed against major antigens induced by cowpox virus (CPV) were produced. The specificities of these antibodies were established by immunoprecipitation, immunoblotting and several serological analyses, and from the cross-reactivities of these antibodies with cells infected with various other poxviruses, ectromelia virus (EV), vaccinia virus and Shope fibroma virus. The antibodies defined included ones reacting with each of the known major antigens of poxviruses, i.e. the common antigen of all poxviruses (probably NP antigen), the Orthopoxvirus-specific antigen (probably LS antigen), the haemagglutinin, the cell surface antigen, the common A-type inclusions in CPV and EV, and the antigen involved in neutralization.
not yet been reported. In this work, using newly obtained monoclonal antibodies directed against CPV, we analysed the polypeptides of these major antigens (NP, LS, HA, CS and ATI) and the neutralization (NT)-associated antigen by immunoprecipitation, immunoblotting and several biological analyses.
RK13 cells derived from rabbit kidney cells, HeLa ceils derived from a human carcinoma and L cells derived from mouse fibroblasts were grown in minimum essential medium supplemented with 5~ calf serum (MEM-CS). The strains of CPV used were LB red, LB white, Amsterdam, 53, 58 and 60 strains, EV strains were Ishibashi and Hampstead, VV strains were Ikeda, Lister, IHD-W, IHD-J and Dis, and the SFV strain was OA. RK13 or HeLa cells were infected with CPV, VV or SFV, and HeLa or L cells were infected with EV. The methods for production and culture of hybridomas and the screening procedures for antibodies have been described previously (Kitamoto et al., 1984) . Hybridomas were obtained from cultures of myeloma cells fused with spleen cells from mice immunized with cells infected with the LB red strain of CPV. Ascites fluids obtained as described previously (Kitamoto et al., 1986a) were used as monoclonal antibodies. The subclasses of these antibodies were determined by immunodiffusion with a hybridoma cell lysate and class-specific immunoglobulin antisera as described by Volk et al. (1982) . The indirect IF test was carried out with cells infected with each virus at a m.o.i, of 10, cultured for 24 h after infection and fixed with cold acetone. For the membrane IF (MIF) test, cells infected (m.o.i. 10) and cultured for 2.5 h were used without fixation. The haemagglutination inhibition (HAI) test was done as described by Payne & Norrby (1976) with cells infected with each virus as antigens. For the NT test, about 200 p.f.u, of virus was incubated for 60 min at 37 °C with serial dilutions of monoclonal antibodies in MEM-CS. The virus-antibody sample was adsorbed to HeLa cells for 60 min at 37 °C. After 48 to 64 h of incubation at 37 °C, plaques were visualized by staining with 0.13 ~o crystal violet in 2 ~ ethanol. The titre of antibodies was determined as the reciprocal of the highest fourfold dilution neutralizing 50 ~ of the p.f.u.. For immunoprecipitation, mock-infected and infected (24 h after infection, m.o.i. 10) cells were labelled with 5 ~tCi/ml [35S]methionine (1250 Ci/ml, Amersham) for 24 h and solubilized in TD buffer (1 ~ Triton X-100, 0.5~ sodium deoxycholate, 0.15 MNaC1, 1 mM-phenylmethylsulphonyl fluoride, 10 mM-sodium phosphate buffer pH 7.2) as described previously (Ikuta et al., 1978) . TD lysates were treated with monoclonal antibodies and subjected to SDS-PAGE. The conditions for SDS-PAGE and fluorography were as described previously (Ikuta et al., 1978) . The techniques for immunoblotting (Western blotting) with monoclonal antibodies by the method of Towbin et al. (1979) with slight modifications have been described in detail elsewhere (Kitamoto et al., 1986a) . Mock-infected and infected (24 h after infection, m.o.i. 10) cells were solubilized in sample buffer (3~ SDS, 3~ 2-mercaptoethanol, 10~ glycerol, 0-001 ~ bromophenol blue in 62.5 mM-Tris-HCl pH 6.8).
Thirty-two hybrid clones established from mice immunized with CPV were found to produce viral antibodies. Of these, seven clones that reacted with each major antigen were selected and characterized according to their immunoprecipitation, immunoblotting and IF staining patterns, and by other biological tests. Other clones could not be identified, because their reactivities varied under the test conditions used. Most antibodies were characterized according to their IF staining patterns and biological tests as described previously (Kitamoto et al., 1984) . However, some antibodies did not react with any polypeptide by either immunoprecipitation or immunoblotting and others reacted with not only major polypeptides but also several unidentified minor polypeptides on immunoprecipitation and/or immunoblotting. Therefore, they will not be considered in this article. Results on the reactivities of seven monoclonal antibodies directed against major antigens are summarized in Table 1 and are described below in detail.
The NP1 and NP2 monoclonal antibodies gave positive reactions with all cells infected with CPV, EV, VV or SFV on immunoblotting and in the IF test (Table 1) . NP1 reacted with a polypeptide with a mol. wt. of 65 000 (65K) in infected cells on both immunoprecipitation (Fig.  1) and immunoblotting (Fig. 2) , and gave a granular cytoplasmic fluorescence staining pattern in the IF test (Fig. 3a) . On the other hand, NP2 reacted with a 40K polypeptide on immunoprecipitation ( Short communication (Fig. 2) , and gave a pin spot-like cytoplasmic fluorescence staining pattern (Fig. 3 b) . These antibodies gave negative reactions in the HAI, NT and MIF tests, and with mock-infected cells in all tests. The cross-reactivities of NP2 with each virus and with the 65K polypeptide were the same as those of NP1. However, the IF staining pattern of, and polypeptides precipitated by NP2 and NP1 appeared to be different. This was examined by peptide mapping experiments involving the partial proteolysis of these 65K polypeptides by V8 protease digestion (Cleveland et at., 1977) . The peptide pattern of the 65K polypeptide reacting with NP2 was different from that recognized by NP1 (data not shown). Both these antibodies recognized a common antigen in all the poxviruses (probably NP antigen, although this has not been absolutely established), since they both reacted with the 65K and/or 40K polypeptide (Ikuta et al., 1979a) and crossreacted with all poxvirus-infected cells (Woodroofe & Fenner, 1962) . We also found that the 65K and/or 40K polypeptide was detected by immunoblotting of CPV virions purified from infected cells (data not shown). Wilton et al. (1986) reported several monoclonal antibodies against VV which recognized core complex components and reacted with cytoplasmic inclusions (called Btype inclusions) ranging widely in size. The possibility is that the NP proteins are highly immunogenic antigens and have many epitopes. The NP antigen is associated with B-type inclusions, but not with ATI (Kato et al., 1959b) . Further studies on the relation between NP1 and NP2 antibodies and between B-type inclusions and ATI are in progress. The LS1 antibody cross-reacted with cells infected with CPV, EV or VV, but not with SFV in the IF test (Table 1) . This antibody reacted with a 100K polypeptide in infected cells on immunoprecipitation (Fig. 1) . However, no polypeptide was detected in any virus-infected cells on immunoblotting (Table 1 and Fig. 2 ). The antibody showed diffuse cytoplasmic fluorescence staining in the IF test (Fig. 3 c) , and gave negative reactions in the HAl, NT and MIF tests. The antibody also gave negative reactions with mock-infected cells in all tests. Although the identification of the LS antigen has not been absolutely established, it is probable that LSI recognizes one of the LS antigens, since it reacted with a 100K polypeptide (Ikuta et al., 1979b) and with cells infected with an Orthopoxvirus, but not a Leporipoxvirus (Gispen, 1955; Rondle & Dumbell, 1962) . However, our previous studies with polyclonal antibody (Ikuta et al., 1979b) showed that the 100K polypeptide was present in cells infected with VV, but not with CPV. Our monoclonal antibody reacted with the 100K polypeptide in both CPV-infected cells and VVinfected cells. Moreover, we obtained hybridomas from mice immunized with the VV Lister strain that showed surface-diffuse staining for IF (Kitamoto et al., 1984) and reacted with the 100K polypeptide in both ! CPV-and VV-infected cells (unpublished data). These differences may be due to the relative specificities or sensitivities of the polyclonal antibody and the monoclonal antibody. Another possibility is that the 100K polypeptide in LS molecules has distinct epitopes, because it was detected on immunoprecipitation but not on immunoblotting. This may be because the antigen has different conformations under the different conditions used, resulting in exposure of different epitopes and thus having different reactivities with the ,monoclonal antibody. Similar observations have been reported previously (Molday & MacKenzie, 1983; Kuismanen et aL, 1984) . Another possibility is that these differences may be due to the methods of preparing the antigens, i.e. the sample buffer conditions used for immunoblotting and immunoprecipitation.
The HA1 antibody had HA1 activity (Table 1) and reacted with an 85K polypeptide in infected cells on immunoprecipitation (Fig. 1) and immunoblotting (Fig. 2) . In the IF test and on immunoblotting, this antibody cross-reacted with cells infected with CPV, EV or VV including the Ikeda, Lister and IHD-J strains, but did not react with cells infected with the VV IHD-W strain, which have no HA (Kaku & Kamahora, 1964) . The HA1 antibody showed cell surface staining in the IF test (Fig. 3d) . These results are consistent with previous findings using VV monoclonal antibodies (Dales et al., 1983; Wilton et at., 1986) . The antibody gave negative reactions in the NT and MIF tests, and also negative reactions with mock-infected cells in all tests.
The CSI antibody showed cell surface staining in the IF test (Fig. 3e) and gave a positive reaction with the cell membrane of living cells at an early stage of infection (2.5 h) in the MIF test (Table 1) and MIF tests. This strain cannot multiply in RK13 cells and expresses only the early CS antigen, although it can grow and produce plaques in chick embryo fibroblast cells (Ueda et al., 1972) . Moreover, the antibody gave a POsitive reaction with infected cells cultured in the presence of cytosine-1-/~-D-arabinofuranosyI-HCl in the IF test. This antibody reacted with a 43K polypeptide on immunoblotting (Fig. 2) , although it did not react with any polypeptide on immunoprecipitation (Fig. 1) . For a reason similar to that described above for the LS antigen, the failure to detect a polypeptide reacting with the CS1 antibody on immunoprecipitation whereas a 43K polypeptide was found on immunoblotting may not be the result of differences in the amounts of cleavage products, but rather may be due to a lack of reactivity. On immunoblotting, besides the 43K polypeptide two others were detected in virus-infected cells, as shown in Fig. 2 (indicated by arrowheads) . However, these two polypeptides may not be virusspecific, because they were also detected in mock-infected cells (data not shown). The antibody gave negative reactions with mock-infected cells in other tests and the HAl and NT tests. The existence of two types of early CS antigen (major early CS and minor early CS antigens) has been demonstrated by mixed agglutination (Ito & Barron, 1972) ; the Lister strain of VV is reported to have a defect in the major early CS antigen, but to produce the minor early CS antigen (Ito & Barron, 1972; Amano et al., 1979) . Since the CS1 antibody obtained in this study reacted with cells infected with the VV Lister strain, it may recognize the minor early CS antigen, or one of the several CS antigens. We have also reported that hybridomas obtained from mice immunized with the VV Ikeda strain may recognize the minor CS antigen (Kitamoto et al., 1984) . The A212 monoclonal antibody reacted with cytoplasmic ATI in CPV-or EV-infected cells, but not in VV-or SFV-infected cells in the IF test (Table 1 ). The fluorescence showed roughly homogeneous intensity throughout the interior of ATI in CPV-or EV-infected cells (dense solid ATI staining pattern, Fig. 3f ). This antibody reacted with an 80K polypeptide in CPV-or EV-infected cells on immunoprecipitation (Fig. 1) and immunoblotting (Fig. 2) , but not in other virus-infected cells. Negative reactions were obtained in the HAI, NT and MIF tests, and with mock-infected cells in alI tests. Previously, we reported the establishment of monoclonal antibodies against ATI and classified them into at least three groups: strain-specific (group I), CPV-and EV-specific (group II) and Orthopoxvirus-specific (group III) antibodies (Kitamoto et at., 1986b) . The A212 antibody obtained in this experiment belongs to group IL since it crossreacted with AT1 in CPV-or EV-infected cells. However, the IF staining and immunoprecipitation patterns of this antibody were different from those of other antibodies in group II. The dense solid ATI and the 80K polypeptide reacting with A212 are common to all the CPV and EV strains, while the surface-oriented ATI (shown in Fig. 3g ; At antibody described previously by Kitamoto et al., 1986a) and the 160K polypeptide reacting with other antibodies (Kitamoto et al., 1986b) vary from strain to strain. Therefore, the former may represent a common ATI in Orthopoxvirus, whereas the latter may be virus-or strain-specific. All the monoclonal antibodies that reacted with the 160K polypeptide in CPV-infected cells gave surface-oriented ATI staining patterns in the IF test (Kitamoto et al., 1986b) . However, in spite of their similarities, on peptide mapping the reactions of the 160K polypeptide with the antibodies showed distinct patterns, indicating that there is a clear difference in the primary amino acid sequences of ATI proteins recognized by each monoclonal antibody (data not shown).
The NT1 monoclonal antibody had neutralizing activity (Table 1) , and reacted with 27K and 28K polypeptides on immunoprecipitation (Fig. 1 ) and on immunoblotting (Fig. 2) . This antibody gave positive reactions with cells infected with CPV, EV or VV, but not with SFV in the IF and NT tests, and was positive on immunoblotting (Table 1) . The reaction was positive in the MIF test, but not in the HAt test. IF staining by this antibody was of the surface and of cytoplasmic granules (Fig. 3 h) . The antibody gave negative reactions with mock-infected cells in all tests. Recently, monoclonal antibodies recognizing an envelope protein of VV have been reported to show neutralizing activity and to react with the 14K polypeptide (Rodriguez et aL, 1985) or the 28K polypeptide (M. Oie & Y. Ichihashi, personal communication, 1985) . Our NT1 antibody directed against CPV also had neutralizing activity and reacted wih the 28K polypeptide. This antibody cross-reacted with cells infected with EV and VV. Therefore, the 28K polypeptide associated with neutralization shows a high degree of protein conservation in
